Evidence map›Paper›PMID 38178179›Full record

ReviewGenome biology2024

From beer to breadboards: yeast as a force for biological innovation.

Hamid Kian Gaikani, Monika Stolar, Divya Kriti, Corey Nislow, Guri Giaever

Abstract readReview
In one paragraph

Review in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Yeast as a Model for Human Disease.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Investigating the Consequences of Aneuploidy in Cancer and Normal Tissue.Advances in experimental medicine and biology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Backstage Heroes-Yeast in COVID-19 Research.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamid Kian GaikaniFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Monika StolarFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Divya KritiFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Corey NislowFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. corey.nislow@ubc.ca.ORCID 0000-0002-4016-8874
Guri GiaeverFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The history of yeast Saccharomyces cerevisiae, aka brewer's or baker's yeast, is intertwined with our own. Initially domesticated 8,000 years ago to provide sustenance to our ancestors, for the past 150 years, yeast has served as a model research subject and a platform for technology. In this review, we highlight many ways in which yeast has served to catalyze the fields of functional genomics, genome editing, gene-environment interaction investigation, proteomics, and bioinformatics-emphasizing how yeast has served as a catalyst for innovation. Several possible futures for this model organism in synthetic biology, drug personalization, and multi-omics research are also presented.

Indexed as

BeerSaccharomyces cerevisiae

Identifiers

PMID38178179
PMCPMC10768129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.